A detailed history of Gsa Capital Partners LLP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 240,522 shares of RPTX stock, worth $324,704. This represents 0.06% of its overall portfolio holdings.

Number of Shares
240,522
Previous 299,654 19.73%
Holding current value
$324,704
Previous $989,000 16.38%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$2.75 - $3.99 $162,613 - $235,936
-59,132 Reduced 19.73%
240,522 $827,000
Q2 2024

Aug 15, 2024

BUY
$3.02 - $4.7 $523,806 - $815,196
173,446 Added 137.43%
299,654 $989,000
Q1 2024

May 03, 2024

SELL
$4.53 - $8.41 $82,636 - $153,415
-18,242 Reduced 12.63%
126,208 $594,000
Q4 2023

Feb 16, 2024

BUY
$3.22 - $11.79 $390,614 - $1.43 Million
121,309 Added 524.22%
144,450 $1.05 Million
Q3 2023

Nov 15, 2023

BUY
$8.16 - $13.01 $188,830 - $301,064
23,141 New
23,141 $279,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.